Vinit Bharati Mahajan, MD PHD
Ophthalmology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mahajan’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A83613 · Current
Licensed to practise in California · since 2003 · expires 2028-12-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$23,554 in 2022
Medicaid paid $23,554 for 459 billed services this clinician did in 2022, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Intravitreal injection of a pharmacologic agent (separate procedure) | 70 | $14,776 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 285 | $5,125 |
| Return visit (30+ min) | 104 | $3,652 |
| 2022 | 459 | 3 | 42 | $23,554 |
| 2021 | 459 | 3 | 41 | $22,538 |
| 2020 | 222 | 3 | 30 | $6,399 |
| 2019 | 274 | 2 | 28 | $11,849 |
| 2018 | 57 | 1 | 21 | $1,270 |
See the largest Medicaid services in earlier years
2021
| Intravitreal injection of a pharmacologic agent (separate procedure) | 63 | $15,214 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 303 | $4,613 |
| Return visit (30+ min) | 93 | $2,711 |
2020
| Intravitreal injection of a pharmacologic agent (separate procedure) | 15 | $3,196 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 160 | $1,990 |
| Return visit (30+ min) | 47 | $1,214 |
2019
| Intravitreal injection of a pharmacologic agent (separate procedure) | 35 | $7,917 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 239 | $3,931 |
2018
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 57 | $1,270 |
Money from drug and device companies
$264 in 2025
| 2025 | 3 | 4 | None | $264 |
| 2024 | 1 | 1 | $6,075 | $6,075 |
| 2023 | 1 | 2 | $3,575 | $3,597 |
| 2022 | 2 | 2 | None | $244 |
| 2019 | 1 | 1 | None | $29 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Izervay | $167 | 2 payments
|
| Alcon Vision | None | $50 | 1 payment
|
| Harrow Eye | None | $48 | 1 payment
|
See all 4 published payments
| Astellas Pharma US | Meals · 2025-11-11 | Izervay | $91 |
| Harrow Eye | Meals · 2025-08-02 | None | $48 |
| Alcon Vision | Meals · 2025-08-01 | None | $50 |
| Astellas Pharma US | Meals · 2025-08-01 | Izervay | $75 |
See earlier years (2024, 2023, 2022, 2019)
2024: $6,075
| Merck Sharp & Dohme | None | $6,075 | 1 payment
|
2023: $3,597
| Janssen Research & Development | None | $3,597 | 2 payments
|
2022: $244
| Abbvie | Ozurdex | $124 | 1 payment
|
| Genentech | Vabysmo | $120 | 1 payment
|
2019: $29
| Mallinckrodt Enterprises | Acthar | $29 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Janssen Research & Development, LLC · 2024 | Their institution | $62,192 |
| Janssen Research & Development, LLC · A Phase 2/3, Randomized, Double-Masked, Multicenter, Dose-Ranging, Sham-Controlled Clinical Trial To Evaluate Intravitreal Jnj-81201887 (Aavcagscd59) Compared To Sham Procedure for the Treatment of Geographic Atrophy (Ga) Secondary To Age-Related Macular · 2023 | Their institution | $27,239 |
| Janssen Research & Development, LLC · A Phase 2/3, Randomized, Double-Masked, Multicenter, Dose-Ranging, Sham-Controlled Clinical Trial To Evaluate Intravitreal Jnj-81201887 (Aavcagscd59) Compared To Sham Procedure for the Treatment of Geographic Atrophy (Ga) Secondary To Age-Related Macular · 2024 | Their institution | $24,755 |
| Janssen Research & Development, LLC · A Phase 2/3, Randomized, Double-Masked, Multicenter, Dose-Ranging, Sham-Controlled Clinical Trial To Evaluate Intravitreal Jnj-81201887 (Aavcagscd59) Compared To Sham Procedure for the Treatment of Geographic Atrophy (Ga) Secondary To Age-Related Macular · 2025 | Their institution | $12,775 |
| Janssen Research & Development, LLC · Gene Therapy Trial for the Treatment of X-Linked Retinitis Pigmentosa Associated With Variants in the Rpgr Gene · 2025 | Their institution | $10,703 |
| Janssen Research & Development, LLC · Follow-Up Gene Therapy Trial for the Treatment of X-Linked Retinitis Pigmentosa Associated With Variants in the Rpgr Gene · 2025 | Their institution | $7,201 |
| Janssen Research & Development, LLC · Mgt-Rpgr-022 · 2024 | Their institution | $5,833 |
| Janssen Research & Development, LLC · Mgt-Rpgr-022 · 2023 | Their institution | $3,790 |
| Janssen Research & Development, LLC · Mgt-Rpgr-021 · 2024 | Their institution | $2,560 |
Professional record
- NPI
- 1497784300
- Licence
- CA A83613, IA 36642California A83613: Current · expires 2028-12-31
More record details
- Sole proprietor
- No
- Medicaid ID
- IA 0730002
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 7999 Gateway Blvd Ste 200, Newark, CA, 94560
- NPI first listed
- 2006-07-02
- NPI last updated
- 2020-03-02
- NPI record certified
- 2020-03-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 15425 Los Gatos Blvd Ste 120, Los Gatos, CA, 95032